2010
DOI: 10.1177/197140091002300212
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Flow-Diverting Stents in the Treatment of Giant Cerebral Aneurysms: Preliminary Results

Abstract: The treatment of giant cerebral aneurysms has always been a challenge for neurosurgeons and neuroradiologists. Flow-diverting stents (Silk; Pipeline Embolization Device) are new endovascular devices introduced for the treatment of intracranial aneurysms without release of intrasaccular coils. They are tubular bimetallic endoluminal devices with low porosity. We have employed these stents in the Neuroradiology Unit of Bellaria Hospital (Bologna, Italy) since the end of 2008, treating nine patients with giant ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
19
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(22 citation statements)
references
References 12 publications
3
19
0
Order By: Relevance
“…[1][2][3][4] High rates of complete aneurysm occlusion have been reported, even in large and giant aneurysms, with the use of endoluminal flow diverters. [1][2][3][4][5][6][7] The Pipeline Embolization Device (PED; Covidien, Irvine, California) received CE mark approval in 2008 for the embolization of cerebral aneurysms and received US FDA approval in 2011 (PMA P100018) for the treatment of large and giant wideneck aneurysms in the internal carotid artery, from the petrous to the superior hypophyseal segments. While numerous previous studies have reported overall rates of adverse events similar to those in other endovascular procedures, case reports and small case series documenting severe and "unexpected" complications have raised questions about the safety of these devices.…”
Section: Abbreviationsmentioning
confidence: 99%
“…[1][2][3][4] High rates of complete aneurysm occlusion have been reported, even in large and giant aneurysms, with the use of endoluminal flow diverters. [1][2][3][4][5][6][7] The Pipeline Embolization Device (PED; Covidien, Irvine, California) received CE mark approval in 2008 for the embolization of cerebral aneurysms and received US FDA approval in 2011 (PMA P100018) for the treatment of large and giant wideneck aneurysms in the internal carotid artery, from the petrous to the superior hypophyseal segments. While numerous previous studies have reported overall rates of adverse events similar to those in other endovascular procedures, case reports and small case series documenting severe and "unexpected" complications have raised questions about the safety of these devices.…”
Section: Abbreviationsmentioning
confidence: 99%
“…our cohort has already been described in detail 6,18 . Briefly, between december 2007 and december 2010 we treated 29 unruptured aneurysms and one blister-like aneurysm 30 days after SAH deploying a Silk stent to cover the aneurysm neck.…”
Section: Methodsmentioning
confidence: 99%
“…We always managed to reach the position for stent deployment without encountering differences in the stability of the system or vessel wall injury between the vASCO 21 microcatheter (calibre 0.0021") and the vASCO 25 (calibre 0.0025") 6,18 .…”
Section: Intraprocedural Problems Perforation Of a Distal Arteriolementioning
confidence: 99%
See 1 more Smart Citation
“…Occlusion of large side branches by stent placement has not been reported to the best of our knowledge. Furthermore, immediate or delayed occlusion of the ophthalmic artery or important side branches is rarely reported even when using a high surface coverage flow diverter stent in the paraclinoid carotid artery 6,7 . Although this mechanism seems unlikely, we could not deny the possibility of branch occlusion because of lack of angiographic study at the occurrence of the symptom.…”
Section: Casementioning
confidence: 99%